The role of the cyclooxygenase-2 - prostaglandin E2 cascade in pancreatic cancer associated angiogenesis
Citation:
Desmond P. Toomey, 'The role of the cyclooxygenase-2 - prostaglandin E2 cascade in pancreatic cancer associated angiogenesis', [thesis], Trinity College (Dublin, Ireland). School of Medicine. Discipline of Surgery, 2010, pp 147Download Item:
Abstract:
Medical therapy has failed to make any significant impact on survival in pancreatic cancer. Non Steroidal Anti-inflammatory Drugs (NSAIDs) have shown promise in several gastrointestinal (Gl) cancers. Evidence has suggested a similar effect in pancreatic cancer. Cyclooxygenase-2 (COX-2), a major target of NSAIDs, is upregulated in pancreatic cancer and is associated with worse prognosis. COX-2 upregulation has been shown to correlate with angiogenesis and production of pro- angiogenic growth factors, especially Vascular Endothelial Growth Factor (VEGF), in several Gl cancers. Although this relationship between COX-2 and angiogenesis in pancreatic cancer would seem a viable target, clinical trials of COX-2 or VEGF inhibitors have demonstrated no survival benefit.
Author: Toomey, Desmond P.
Advisor:
Conlon, KevinQualification name:
Doctor of Medicine (M.D.)Publisher:
Trinity College (Dublin, Ireland). School of Medicine. Discipline of SurgeryNote:
TARA (Trinity’s Access to Research Archive) has a robust takedown policy. Please contact us if you have any concerns: rssadmin@tcd.ieType of material:
thesisAvailability:
Full text availableKeywords:
Surgery, M.D., M.D. Trinity College DublinMetadata
Show full item recordLicences: